Topics

Michael E. Cain, MD, vice president for health sciences, has been honored with a Leadership Buffalo Value Award for inclusion.

The UB Clinical and Translational Science Institute showcased award-winning studies and novel technologies developed jointly by UB researchers and collaborators.

Yijun Sun, PhD, assistant professor of microbiology and immunology, is using a $519,000 award from the National Science Foundation to develop novel analytic methods for the study of microbial communities.

Paresh Dandona, MD, PhD, Distinguished Professor of medicine, is studying liraglutide, potentially a major new treatment for Type 1 diabetes.

UB researchers found that aerobic exercise may help restore normal cognitive function in patients who have suffered a concussion.

Virginia Havel, a PhD student in microbiology and immunology, has received an American Heart Association Founders Affiliate predoctoral fellowship.

Sarah X. Zhang, MD, is studying a possible mechanism underlying retinopathy and testing a novel protective agent to thwart it.

Researchers have discovered a new vaccine target for tuberculosis using a UB-patented adjuvant that boosts the potency of mucosal vaccines.

Barry S. Willer, PhD, has received the 2012 Research Award from the North American Brain Injury Society.

Innovations developed at least in part by faculty at UB’s School of Medicine and Biomedical Sciences accounted for nearly 40 percent of the provisional patent applications filed by the university in 2012.

UB researchers have identified specific roles for two innate immune pathways that drive acute lung injury—findings that may lead to the first treatment or preventive strategy for the condition.

UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.

Kate Rittenhouse-Olson, PhD, professor of biotechnical and clinical laboratory sciences, and Ernesto De Nardin, PhD, adjunct professor of microbiology and immunology, have co-authored a clinical immunology textbook.

Patient Voices Network, a partnership between the Department of Family Medicine’s Primary Care Research Institute and Jericho Road Ministries, recently held a free breast cancer awareness event on Buffalo’s East Side.

Laurie K. Read, PhD, has won a four-year, $1.6 million NIH grant to study the mechanisms and regulation of RNA editing in the parasite responsible for African sleeping sickness.

Biochemistry professor Mark R. O’Brian, PhD, has won a $1.1 million grant from the National Institutes of Health to study regulation of bacterial manganese metabolism.